欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0940/001
药品名称Quatriga Perifer
活性成分
    • Alanine 4.4 g
    • Arginine 3.8 g
    • Calcium chloride dihydrate 0.18 g
    • fish oil, rich in omega 3-acids 4.2 g
    • ANHYDROUS DEXTROSE monohydrate 71.0 g
    • Glycine 3.5 g
    • Histidine 0.93 g
    • Isoleucine 1.6 g
    • leucine 2.3 g
    • Lysine acetate 2.1 g
    • Magnesium sulfate 0.38 g
    • medium-chain triglycerides 8.5 g
    • Methionine 1.3 g
    • OLIVE OIL monohydrate 7.0 g
    • PHENYLALANINE L 1.6 g
    • Potassium chloride 1.4 g
    • Proline 3.5 g
    • Serine 2.1 g
    • Sodium acetate 1.1 g
    • SODIUM GLYCEROPHOSPHATE hydrate 1.3 g
    • SOYBEAN OIL monohydrate 8.5 g
    • Taurine 0.32 g
    • Threonine 1.4 g
    • (2S)-2-AMINO-3-(1H-INDOL-3-YL)PROPANOIC ACID 0.63 g
    • Tyrosine 0.12 g
    • Valine 2.0 g
    • Zinc sulfate 0.0 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
许可日期2010/03/02
最近更新日期2024/12/02
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase